Serum Institute COVID Vaccine Shot, Adverse Reaction Not Rel
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A 40-year-old man who was a volunteer in the third phase of the vaccine trial in Chennai claimed to have suffered serious neurological and psychological symptoms after taking the experimental shot. He has sued the SII along with others and sought compensation of Rs 5 crore, besides seeking a halt to the trial.

A probe initiated by the Drugs Controller General of India (DCGI) into an alleged "serious adverse event" has found that it was not related to the shot administered to him and rejected the charges of vaccine being malicious and misconceived.

An independent expert panel was constituted by the DCGI to look into the claim of a the event during the Serum Institute trial at a site in Chennai and after due deliberation they reported that SAEs were not related to vaccine/clinical trial.

Therefore, the committee recommends a compensation not to be paid to the subject or legal heir/ nominee of the subject, the panel said in its recommendation. Pune-based vaccine manufacturer SII said that the vaccine is safe and immunogenic.

Source:
https://www.business-standard.com/article/current-affairs/dcgi-finds-no-link-between-covid-vaccine-shot-adverse-reaction-report-120120201293_1.html
Like
Comment
Share